Sackler Prize Convergence
About the Raymond and Beverly Sackler Prize in Convergence Research
The Raymond and Beverly Sackler Prize in Convergence Research recognized significant advances in convergence research—the integration of two or more of the following disciplines: mathematics, physics, chemistry, biomedicine, biology, astronomy, earth sciences, engineering, and computational science—for achievements possible only through such integration.
Recipients:
Joseph M. DeSimone (2018)
For integrating chemistry, physics, and engineering disciplines to invent platform technologies that have transformed aspects of nanomedicine and 3D-printing.
Frances H. Arnold (2017)
For her pioneering directed molecular evolution strategies, used worldwide to optimize the functions of enzymes and to engineer cells to produce biofuels and chemicals from renewable resources.
Read more about Arnold's work»
Stephen R. Quake (2016)
For his innovative technological advances in microfluidics and genomics that made possible new non-invasive diagnostic procedures to detect at the single cell and single molecule levels a variety of disease conditions, such as brain tumors and the rejection of transplanted organs, as well as the prenatal diagnosis of genetic diseases
Read more about Quake's work»
Chad A. Mirkin (2015)
For impressively integrating chemistry, materials science, molecular biology, and biomedicine in the development of spherical nucleic acids and new types of nanostructures that are widely used in the rapid and automated diagnosis of infectious diseases and many other human diseases—including cancers and cardiac disease—and in the detection of drug-resistant bacteria.
Read more about Mirkin's work»
Read the Press Release»
For impressively integrating chemistry, materials science, molecular biology, and biomedicine in the development of spherical nucleic acids and new types of nanostructures that are widely used in the rapid and automated diagnosis of infectious diseases and many other human diseases—including cancers and cardiac disease—and in the detection of drug-resistant bacteria.
Read more about Mirkin's work»
Read the Press Release»
